COVID-19 mRNA Vaccines Safe During Pregnancy
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 13, 2024 -- Vaccination of pregnant individuals with mRNA COVID-19 vaccines is not associated with increased risks for neonatal adverse events, according to a study published online in the Feb. 6 issue of the Journal of the American Medical Association.
Mikael Norman, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined associations between exposure to mRNA COVID-19 vaccination during pregnancy and adverse events in newborn infants. The analysis included 94,303 infants in Sweden and Norway who were exposed to COVID-19 vaccination during pregnancy and 102,167 control infants (born June 2021 to January 2023).
The researchers found that exposed infants did not have increased odds of adverse neonatal outcomes, and they exhibited lower odds for neonatal nontraumatic intracranial hemorrhage (event rate, 1.7 versus 3.2 per 1,000; adjusted odds ratio [aOR], 0.78), hypoxic-ischemic encephalopathy (1.8 versus 2.7 per 1,000; aOR, 0.73), and neonatal mortality (0.9 versus 1.8 per 1,000; aOR, 0.68). Similar associations were seen for term infants, singleton births, or infants without birth defects. No differences were seen by vaccine manufacturer.
"The current study’s results could not elucidate the mechanisms that explain why infants of vaccinated individuals had lower risks of some outcomes including mortality," the authors write. "Unmeasured confounding due to vaccinated individuals being healthier may have contributed to the lower neonatal morbidity and mortality associated with COVID-19 vaccination during pregnancy."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
Cannabis Use Tied to Risk of COVID-19 Hospitalizations, ICU Admissions
TUESDAY, June 25, 2024 -- Current cannabis use may be an independent risk factor for COVID-19–related complications, according to a study published online June 21...
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.